These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4631013)

  • 21. Interaction of human serum high density lipoproteins with triglycerides in vitro.
    Koren E; Marić Z; Milković S
    FEBS Lett; 1974 Aug; 44(1):43-9. PubMed ID: 4368829
    [No Abstract]   [Full Text] [Related]  

  • 22. Sensitivity of thrombin and plasmin to heparin and antithrombin III.
    Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I
    Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoform composition of antithrombin in a covalent antithrombin-heparin complex.
    Chan AK; Berry LR; Paredes N; Parmar N
    Biochem Biophys Res Commun; 2003 Oct; 309(4):986-91. PubMed ID: 13679071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the interaction of heparin with thrombin, antithrombin, and other plasma proteins.
    Longas MO; Ferguson WS; Finlay TH
    Arch Biochem Biophys; 1980 Apr; 200(2):505-602. PubMed ID: 7436418
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanism of poly(acrylic acid) acceleration of antithrombin inhibition of thrombin: implications for the design of novel heparin mimics.
    Monien BH; Cheang KI; Desai UR
    J Med Chem; 2005 Aug; 48(16):5360-8. PubMed ID: 16078853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of oleic acid, tolbutamide, and oxyphenbutazone on the binding of warfarin by human serum albumin.
    Wosilait WD; Ryan MP
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):577-84. PubMed ID: 504792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoelectrophoretic quantitation of antithrombin III. Electroimmunodiffusion in agarose gels containing heparin.
    Grimmer O; Fagerhol MK
    Int J Pept Protein Res; 1977; 9(2):85-90. PubMed ID: 402327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation, characterization and detection of a ternary complex between S protein, thrombin and antithrombin III in serum.
    Preissner KT; Zwicker L; Müller-Berghaus G
    Biochem J; 1987 Apr; 243(1):105-11. PubMed ID: 3606566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routes of thrombin action in the production of proteolytically modified, secondary forms of antithrombin-thrombin complex.
    Fish WW; Orre K; Björk I
    Eur J Biochem; 1979 Nov; 101(1):39-44. PubMed ID: 510313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparin.
    Marciniak E
    Br J Haematol; 1981 Jun; 48(2):325-36. PubMed ID: 7236529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free fatty acids alter calcium binding: a cause for misinterpretation of serum calcium values and hypocalcemia in critical illness.
    Zaloga GP; Willey S; Tomasic P; Chernow B
    J Clin Endocrinol Metab; 1987 May; 64(5):1010-4. PubMed ID: 3558721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification of antithrombin 'Vicenza': a molecule with normal heparin affinity and impaired reactivity to thrombin.
    Finazzi G; Tran TH; Barbui T; Duckert F
    Br J Haematol; 1985 Feb; 59(2):259-63. PubMed ID: 3970857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.
    Bray B; Lane DA; Freyssinet JM; Pejler G; Lindahl U
    Biochem J; 1989 Aug; 262(1):225-32. PubMed ID: 2818566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new assay for the measurement of total progressive antithrombin.
    Lane JL; Bird P; Rizza CR
    Br J Haematol; 1975 May; 30(1):103-15. PubMed ID: 53064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the mechanism of the rate-enhancing effect of heparin on the thrombin-antithrombin III reaction.
    Holmer E; Söderström G; Andersson LO
    Eur J Biochem; 1979 Jan; 93(1):1-5. PubMed ID: 436823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acceleration of the reaction between thrombin and antithrombin III by non-stoichiometric amounts of heparin.
    Björk I; Nordenman B
    Eur J Biochem; 1976 Sep; 68(2):507-11. PubMed ID: 976270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concentration-dependent effects of fatty acids on warfarin binding to albumin.
    Wilding G; Feldhoff RC; Vesell ES
    Biochem Pharmacol; 1977 Jun; 26(12):1143-6. PubMed ID: 560850
    [No Abstract]   [Full Text] [Related]  

  • 39. Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.
    Björk I; Ylinenjärvi K; Olson ST; Hermentin P; Conradt HS; Zettlmeissl G
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):793-800. PubMed ID: 1417738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of sodium oleate on salicylic acid binding to human serum albumin.
    Schwartz PA; Greene DS; Rhodes CT
    J Pharm Sci; 1980 Nov; 69(11):1345-8. PubMed ID: 7452469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.